Drug details

Cimzia (certolizumab pegol injection)

type of DMARDs, TNF Inhibitors, Immunomodulators

Cimzia (certolizumab pegol) is a TFN blocker indicated for reducing signs and symptoms of Crohn's disease and maintaining clinical response in adult patients with moderately to severely active disease.

This drug may have the following side effects:

• serious infections,
• malignancies, and
• heart failure.

The following drugs are related to Cimzia, either as a replacement or used together:

• Abrilada (adalimumab-afzb injection, for subcutaneous use)
• Clanza CR (aceclofenac tablet, film coated)
• Humira (adalimumab injection solution for subcutaneous administration)
• Idacio (adalimumab-aacf injection)
• Yuflyma (adalimumab-aaty injection)
• Yusimry (adalimumab-aqvh injection)
• Amjevita (adalimumab-atto)
• Hadlima (adalimumab-bwwd injection)
• Hulio (adalimumab-fkjp njection)
• Kineret (anakinra)
• Arava (leflunomide)
• Avsola (infliximab-axxq for injection)
• Azasan (azathioprine)
• Colazal (balsalazide)
• Entocort EC (budesonide)
• Canasa (mesalamine)
• Cataflam (diclofenac potassium immediate-release tablets)
• Cortaren (dexamethasone sodium phosphate injection)
• Nascobal (cyanocobalamin)
• Duexis (ibuprofen and famotidine tablets)
• Duobrii (halobetasol propionate and tazarotene lotion)
• Eticovo (etanercept injection)
• Flagyl (metronidazole)
• Flagyl Injection (metronidazole injection)
• Remicade (infliximab)
• Renflexis (infliximab-abda injection)
• Kevzara (sarilumab injection, for subcutaneous use)
• Meloxicam Tablets (meloxicam)
• Trexall (methotrexate)
• Rasuvo (methotrexate non-pyrogenic solution for a single subcutaneous injection)
• Xatmep (methotrexate oral solution)
• Rheumatrex (methotrexate tablets)
• Skyrizi (risankizumab-rzaa injection)
• Tofidence (tocilizumab-bavi injection)
• Xeljanz (tofacitinib tablets)